FDA clearedNeuro Oncology

Perfusion imaging

By October 8, 2018 October 9th, 2018 No Comments

Perfusion imaging quantifies the characteristics of blood flow in tissues: Dynamic susceptibility contrast MRI quantifies relative cerebral blood volume. These quantitative maps offer information to predict tumor grade and analyze post treatment changes for glioblastoma multiforme, meningioma, astrocytoma and oligodendroglioma.

References:

  • Çoban, G., et al. “Prognostic value of dynamic susceptibility contrast-enhanced and diffusion-weighted MR imaging in patients with glioblastomas.” American Journal of Neuroradiology (2015).
  • Lee, B., et al. “Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.” American Journal of Neuroradiology (2018).

Tools:

  • IB Neuro – FDA cleared, CE marked
  • DSC-MRI analysis tool (Imaging Biometrics)

FDA cleared: FDA cleared

Company: Imaging Biometrics

Leave a Reply